American Journal of Kidney Diseases
Volume 56, Issue 5 , Pages 852-860, November 2010

Predictors of Incident Albuminuria in the Framingham Offspring Cohort

  • Conall M. O'Seaghdha, MD

      Affiliations

    • Renal Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
    • National Heart, Lung and Blood Institute's Framingham Heart Study and the Center for Population Studies, Framingham, MA
  • ,
  • Shih-Jen Hwang, PhD

      Affiliations

    • National Heart, Lung and Blood Institute's Framingham Heart Study and the Center for Population Studies, Framingham, MA
  • ,
  • Ashish Upadhyay, MD

      Affiliations

    • Division of Nephrology, Tufts Medical Center and Tufts University School of Medicine, Boston, MA
  • ,
  • James B. Meigs, MD, MPH

      Affiliations

    • General Medicine Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA
  • ,
  • Caroline S. Fox, MD, MPH

      Affiliations

    • National Heart, Lung and Blood Institute's Framingham Heart Study and the Center for Population Studies, Framingham, MA
    • Division of Endocrinology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
    • Corresponding Author InformationAddress correspondence to Caroline S. Fox, MD, MPH, National Heart, Lung and Blood Institute's Framingham Heart Study, 73 Mt Wayte Ave, Ste 2, Framingham, MA 01702

Received 17 December 2009; accepted 7 April 2010. published online 05 July 2010.

Background

Predictors for incident albuminuria are not well known in population-based cohorts. The purpose of this study is to identify predictors of incident albuminuria in an unselected middle-aged population.

Study Design

Observational cohort study.

Setting & Participants

Framingham Offspring Study participants who attended both the sixth (baseline; 1995-1998) and eighth (2005-2008) examination cycles.

Predictors

Standard clinical predictors were used. Predictors of incident albuminuria were identified using stepwise logistic regression analysis with age and sex forced into the model.

Outcomes & Measurements

Albuminuria was defined as urine albumin-creatinine ratio (UACR) ≥17 mg/g (men) or ≥25 mg/g (women). Individuals with albuminuria at baseline were excluded.

Results

1,916 participants were available for analysis (mean age, 56 years; 54% women). Albuminuria developed in 10.0% of participants (n = 192) during 9.5 years. Age (OR, 2.09; P < 0.001), baseline diabetes (OR, 1.93; P = 0.01), smoking (OR, 2.09; P < 0.001), and baseline log UACR (OR per 1-SD increase in log UACR, 1.56; P < 0.001) were associated with incident albuminuria in a stepwise model. An inverse relationship with female sex (OR, 0.53; P < 0.001) and high-density lipoprotein (HDL) cholesterol level (OR, 0.80; P = 0.007) also was observed. Results were similar when participants with baseline chronic kidney disease (n = 102), defined as estimated glomerular filtration rate <60 mL/min/1.73 m2, were excluded from the model. Age, male sex, low HDL cholesterol level, smoking, and log UACR continued to be associated with incident albuminuria when baseline diabetes (n = 107) was excluded. Age, male sex, and log UACR correlated with incident albuminuria after participants with baseline hypertension were excluded (n = 651).

Limitations

Causality may not be inferred because of the observational nature of the study. One-third of participants did not return for follow-up, potentially attenuating the observed risks of albuminuria.

Conclusions

The known cardiovascular risk factors of increasing age, male sex, diabetes, smoking, low HDL cholesterol level, and albuminuria within the reference range are correlates of incident albuminuria in the general population.

Index Words: Microalbuminuria, albuminuria, proteinuria

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This is a US Government Work. There are no restrictions on its use.

 Originally published online as doi:10.1053/j.ajkd.2010.04.013 on July 5, 2010.

 Because a quorum could not be reached after those editors with potential conflicts recused themselves from consideration of this manuscript, the peer-review and decision-making processes were handled entirely by an Associate Editor (Tazeen H. Jafar, MD, MPH, Aga Khan University) who served as Acting Editor-in-Chief. Details of the journal's procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

PII: S0272-6386(10)00845-0

doi:10.1053/j.ajkd.2010.04.013

American Journal of Kidney Diseases
Volume 56, Issue 5 , Pages 852-860, November 2010